Additional details of treatment will be sought to maximize our knowledge about their effects. The investigators will obtain from enrolled subjects, on an annual basis, deproteinized whole EDTA-blood samples for analysis of lactate, beta-hydroxybutyrate (βOHB), thiamine and thiamine pyrophosphate (TPP), as markers of disease status and treatment efficacy.